Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05144009
Title A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ADC Therapeutics S.A.

diffuse large B-cell lymphoma


Loncastuximab tesirine-lpyl + Rituximab

Age Groups: senior
Covered Countries USA

No variant requirements are available.